Room Temperature Aerosol Dehydration (RTAD) technology is a scalable and cGMP-compatible process. RTAD unlocks continuous production of biological therapies as powder and suspension drug formulations
ULTRA-CONCENTRATED SUSPENSIONS FOR SC ADMINISTRATION
Proven rapid ultra-concentration of mAbs and protein drugs to >400 mg/mL in low-viscosity SC injectable formulations
POWDERED DRUGS WITH ENHANCED STABILITY AND PRESERVED BIOLOGICAL ACTIVITY
Flash dehydration-based formulation process converts liquid biologics into room-temperature-stable drug powders while preserving their biological activity
SCALABLE cGMP-COMPATIBLE MANUFACTURING
Consistent scale-up parameters, verified by digital twin. Deployable on existing spray-drying infrastructure, enabling 5–10x capacity for inhaled powders